Skip to content
  • Careers
  • Blog
  • Contact Us
  • English
    • French
    • German
Nexelis, a Q² Solutions Company
  • What’s Next
  • Our Services
    • Early Development Assays
    • Preclinical
    • Protein Sciences
    • Bioanalytical Services
      • Menu
    • Biomarkers
      • Menu
    • Translational Sciences
    • Assay Development and Technology Transfer
    • High-Throughput Testing
  • Our Expertise
    • Infectious Diseases
      • Vaccine
      • COVID-19
    • Immunotherapy
      • Immuno-oncology
    • Metabolic Diseases
  • About Us
    • About Us
    • Our Sites
      • Laval
      • Seattle
      • Gosselies
      • Indianapolis
      • Marburg
      • Porton Down
    • Our Scientists
  • News & Events
    • News
    • Events
  • Resources

Poster

Auditing a Regulated Study Utiliziing an Electronic Laboratory Notebook (ELN)

August 9, 2011

Author: Abby Bousum and Laurel Branstrator Presented at ndiana/Ohio AAPS Discussion Group Symposium, August 2011

View Poster

Back to Resources

About Nexelis, a Q² Solutions Company

With unrivaled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.

A Q2 Solutions Company


Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

Contact Us

Careers
Quality Assurance
Information Technology

Follow Us LinkedIn Twitter YouTube

© 2022 Nexelis, a Q² Solutions Company. All Rights Reserved.

  • Legal & Compliance
  • Terms of Use
  • What’s Next
  • Our Services
    • Early Development Assays
    • Preclinical
    • Protein Sciences
    • Bioanalytical Services
      • Menu
    • Biomarkers
      • Menu
    • Translational Sciences
    • Assay Development and Technology Transfer
    • High-Throughput Testing
  • Our Expertise
    • Infectious Diseases
      • Vaccine
      • COVID-19
    • Immunotherapy
      • Immuno-oncology
    • Metabolic Diseases
  • About Us
    • About Us
    • Our Sites
      • Laval
      • Seattle
      • Gosselies
      • Indianapolis
      • Marburg
      • Porton Down
    • Our Scientists
  • News & Events
    • News
    • Events
  • Resources
  • Careers
  • Blog
  • Contact Us
  • English
    • French
    • German